Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

 

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

2015-06-01 12:09:35| Logistics - Topix.net

Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology Annual Meeting being held in Chicago from May 29-June 2, 2015. The Company also provided updates on its other targeted tyrosine kinase inhibitor, MGCD516, and spectrum-selective HDAC inhibitor, mocetinostat.

Tags: results presents preliminary inhibitor

Category:Transportation and Logistics

Latest from this category

All news

24.11 Atlantic Tropical Weather Outlook 24.11 Eastern North Pacific Tropical Weather Outlook 24.11 Eastern North Pacific Tropical Weather Outlook 24.11 Atlantic Tropical Weather Outlook 24.11 Atlantic Tropical Weather Outlook 24.11 Eastern North Pacific Tropical Weather Outlook 23.11 Atlantic Tropical Weather Outlook 23.11 Eastern North Pacific Tropical Weather Outlook Transportation and Logistics »

24.11 ISAMI REBELS16oz 24.11 Z 24.11 24.11 4 trail lite 24.11 n-buna song selection 24.11 ()// 24.11 MTG 4 24.11 Jade Flufy Crew Sweat More »